The use of potassium channel blocking agents in the therapy of demyelinating diseases

Paul A. Felts; Kenneth J. Smith

doi:10.1002/ana.410360330

The use of potassium channel blocking agents in the therapy of demyelinating diseases

Paul A. Felts, Kenneth J. Smith

Centre for Anatomy and Human Identification

Research output: Contribution to journal › Letter › peer-review

17 Citations (Scopus)

Original language	English
Pages (from-to)	454
Number of pages	1
Journal	Annals of Neurology
Volume	36
Issue number	3
DOIs	https://doi.org/10.1002/ana.410360330
Publication status	Published - Sept 1994

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1002/ana.410360330

Cite this

@article{9cbe156636fa4016b6409549036b4a99,

title = "The use of potassium channel blocking agents in the therapy of demyelinating diseases",

author = "Felts, {Paul A.} and Smith, {Kenneth J.}",

year = "1994",

month = sep,

doi = "10.1002/ana.410360330",

language = "English",

volume = "36",

pages = "454",

journal = "Annals of Neurology",

issn = "0364-5134",

publisher = "Wiley",

number = "3",

}

TY - JOUR

T1 - The use of potassium channel blocking agents in the therapy of demyelinating diseases

AU - Felts, Paul A.

AU - Smith, Kenneth J.

PY - 1994/9

Y1 - 1994/9

UR - http://www.scopus.com/inward/record.url?scp=0027992396&partnerID=8YFLogxK

U2 - 10.1002/ana.410360330

DO - 10.1002/ana.410360330

M3 - Letter

C2 - 7980830

AN - SCOPUS:0027992396

SN - 0364-5134

VL - 36

SP - 454

JO - Annals of Neurology

JF - Annals of Neurology

IS - 3

ER -

The use of potassium channel blocking agents in the therapy of demyelinating diseases

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this